Literature DB >> 23537959

HIV 2-long terminal repeat circular DNA is stable in primary CD4+T Cells.

Matthew J Pace1, Erin H Graf, Una O'Doherty.   

Abstract

Treatment resistant latent reservoirs remain a barrier to cure HIV, but the maintenance and properties of these reservoirs are not completely understood. 2-LTR circular HIV DNA has been used to assess ongoing viral replication in HAART treated patients. However, the half-life of this DNA form is still debated with conflicting in vivo and in vitro data. Prior in vitro studies have focused on cell lines or short lived activated cells in cultures of brief duration, while in vivo studies have the added complications of cell migration, division, and death. Therefore, we monitored the stability of 2-LTR circles in primary CD4+T cells in a month long culture and compared it to the stability of integrated HIV DNA and T cell receptor excision circles (TRECs), another circular DNA form that is thought to be stable. We found that 2-LTRs, along with TRECs, were stable, suggesting 2-LTRs do not necessarily indicate ongoing replication.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23537959      PMCID: PMC3983779          DOI: 10.1016/j.virol.2013.02.028

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  24 in total

Review 1.  Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs.

Authors:  Mayte Coiras; María Rosa López-Huertas; Mayte Pérez-Olmeda; José Alcamí
Journal:  Nat Rev Microbiol       Date:  2009-11       Impact factor: 60.633

Review 2.  The search for a cure for persistent HIV reservoirs.

Authors:  Alain Lafeuillade; Mario Stevenson
Journal:  AIDS Rev       Date:  2011 Apr-Jun       Impact factor: 2.500

3.  In vivo evidence for instability of episomal human immunodeficiency virus type 1 cDNA.

Authors:  Mark Sharkey; Karine Triques; Daniel R Kuritzkes; Mario Stevenson
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  HIV-1 extrachromosomal 2-LTR circular DNA is long-lived in human macrophages.

Authors:  Laura Gillim-Ross; Andrea Cara; Mary E Klotman
Journal:  Viral Immunol       Date:  2005       Impact factor: 2.257

5.  HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects.

Authors:  Maria J Buzón; Marta Massanella; Josep M Llibre; Anna Esteve; Viktor Dahl; Maria C Puertas; Josep M Gatell; Pere Domingo; Roger Paredes; Mark Sharkey; Sarah Palmer; Mario Stevenson; Bonaventura Clotet; Julià Blanco; Javier Martinez-Picado
Journal:  Nat Med       Date:  2010-03-14       Impact factor: 53.440

Review 6.  T-cell receptor excision circles in primary immunodeficiencies and other T-cell immune disorders.

Authors:  Raz Somech
Journal:  Curr Opin Allergy Clin Immunol       Date:  2011-12

7.  Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy.

Authors:  Sarah Palmer; Frank Maldarelli; Ann Wiegand; Barry Bernstein; George J Hanna; Scott C Brun; Dale J Kempf; John W Mellors; John M Coffin; Martin S King
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-10       Impact factor: 11.205

8.  IL-7 sustains CD31 expression in human naive CD4+ T cells and preferentially expands the CD31+ subset in a PI3K-dependent manner.

Authors:  Rita I Azevedo; Maria Vieira D Soares; João T Barata; Rita Tendeiro; Ana Serra-Caetano; Rui M M Victorino; Ana E Sousa
Journal:  Blood       Date:  2008-11-13       Impact factor: 22.113

9.  Elite suppressors harbor low levels of integrated HIV DNA and high levels of 2-LTR circular HIV DNA compared to HIV+ patients on and off HAART.

Authors:  Erin H Graf; Angela M Mexas; Jianqing J Yu; Farida Shaheen; Megan K Liszewski; Michele Di Mascio; Stephen A Migueles; Mark Connors; Una O'Doherty
Journal:  PLoS Pathog       Date:  2011-02-24       Impact factor: 6.823

10.  Rapid turnover of 2-LTR HIV-1 DNA during early stage of highly active antiretroviral therapy.

Authors:  Weijun Zhu; Yanmei Jiao; Rongyue Lei; Wei Hua; Rui Wang; Yunxia Ji; Zhiying Liu; Feili Wei; Tong Zhang; Xuanlin Shi; Hao Wu; Linqi Zhang
Journal:  PLoS One       Date:  2011-06-08       Impact factor: 3.240

View more
  22 in total

Review 1.  The Alphabet Soup of HIV Reservoir Markers.

Authors:  Radwa R Sharaf; Jonathan Z Li
Journal:  Curr HIV/AIDS Rep       Date:  2017-04       Impact factor: 5.071

2.  An HIV-1 replication pathway utilizing reverse transcription products that fail to integrate.

Authors:  Benjamin Trinité; Eric C Ohlson; Igor Voznesensky; Shashank P Rana; Chi N Chan; Saurabh Mahajan; Jason Alster; Sean A Burke; Dominik Wodarz; David N Levy
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

3.  HIV DNA subspecies persist in both activated and resting memory CD4+ T cells during antiretroviral therapy.

Authors:  John M Murray; John J Zaunders; Kristin L McBride; Yin Xu; Michelle Bailey; Kazuo Suzuki; David A Cooper; Sean Emery; Anthony D Kelleher; Kersten K Koelsch
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

4.  RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection.

Authors:  Wenhui Hu; Rafal Kaminski; Fan Yang; Yonggang Zhang; Laura Cosentino; Fang Li; Biao Luo; David Alvarez-Carbonell; Yoelvis Garcia-Mesa; Jonathan Karn; Xianming Mo; Kamel Khalili
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-21       Impact factor: 11.205

Review 5.  Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications.

Authors:  Véronique Avettand-Fènoël; Laurent Hocqueloux; Jade Ghosn; Antoine Cheret; Pierre Frange; Adeline Melard; Jean-Paul Viard; Christine Rouzioux
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

6.  Persistence of integrated HIV DNA in CXCR3 + CCR6 + memory CD4+ T cells in HIV-infected individuals on antiretroviral therapy.

Authors:  Gabriela Khoury; Jenny L Anderson; Rémi Fromentin; Wendy Hartogenesis; Miranda Z Smith; Peter Bacchetti; Frederick M Hecht; Nicolas Chomont; Paul U Cameron; Steven G Deeks; Sharon R Lewin
Journal:  AIDS       Date:  2016-06-19       Impact factor: 4.177

7.  Experiment Design for Early Molecular Events in HIV Infection.

Authors:  Aditya Jagarapu; LaMont Cannon; Ryan Zurakowski
Journal:  Proc Am Control Conf       Date:  2017-07-03

8.  Order preservation of expected information content using Unscented Transform approximation of multivariate prior distributions in HIV 2-LTR experiment design.

Authors:  George Abraham; Aditya Jagarapu; Lamont Cannon; Ryan Zurakowski
Journal:  Proc IEEE Conf Decis Control       Date:  2016-12

9.  HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy.

Authors:  Guillaume J Besson; Christina M Lalama; Ronald J Bosch; Rajesh T Gandhi; Margaret A Bedison; Evgenia Aga; Sharon A Riddler; Deborah K McMahon; Feiyu Hong; John W Mellors
Journal:  Clin Infect Dis       Date:  2014-07-29       Impact factor: 9.079

Review 10.  Towards an HIV-1 cure: measuring the latent reservoir.

Authors:  Katherine M Bruner; Nina N Hosmane; Robert F Siliciano
Journal:  Trends Microbiol       Date:  2015-03-05       Impact factor: 17.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.